Harpoon Therapeutics
Founded 2015 · CIK 0001708493 · Biotech · Acquired
TriTAC T cell engager platform—bispecific antibody-like molecules that redirect T cells to kill cancer cells
harpoontx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $220M
- 4 Form D · Oct 2023
- 35 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 19 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $25,185,208 | |
| Private capital raised | Form D · SEC | $69,999,993 | |
| Private capital raised | Form D · SEC | $25,000,000 | |
| Private capital raised | Form D · SEC | $100,162,467 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1987 | NATURA THERAPEUTICS, INC. | — | — |
| 1988 | Ultimaxx Health, LLC | — | $10M |
| 1989 | LIGHT SWITCH BIO, LLC | — | — |
| 1990 | Harpoon Therapeutics | — | $220M |
| 1991 | NEOKERA, LLC | — | — |
| 1992 | Primus Pharmaceuticals | — | — |
| 1993 | Acelerox, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Patrick BaeuerleDirector
- Joseph BailesDirector
- Pablo CagnoniDirector
- Mark ChinDirector
- Alan ColowickDirector
- Jonathan DrachmanDirector
- Julie EastlandDirector · Executive Officer
- Georgia ErbezExecutive Officer
- Luke EvninDirector
- Dan HicklinDirector
- Ron HuntDirector
- Ronald HuntDirector
- Gerald McMahonDirector · Executive Officer
- Scott MyersDirector
- William PichtExecutive Officer
- Andrew RobbinsDirector
- Natalie SacksExecutive Officer
- Lauren SilvernailDirector
- Joanne VineyDirector
- Luke WalkerExecutive Officer
- Holger WescheExecutive Officer
Patents
- Single Domain Serum Albumin Binding Proteinapplication
- Trispecific Proteins And Methods Of Useapplication
- Single Domain Serum Albumin Binding Proteingranted
- Epcam Binding Proteins And Methods Of Usegranted
- Binding Moiety For Conditional Activation Of Immunoglobulin Moleculesgranted
- Trispecific Proteins And Methods Of Usegranted
- Trispecific Binding Proteins And Methods Of Useapplication
- Egfr Binding Proteins And Methods Of Usegranted
- Conditional Activation Of Immunoglobulin Moleculesapplication
- B Cell Maturation Antigen Binding Proteinsapplication
- Trispecific Binding Proteins And Methods Of Usegranted
- Bcma Targeting Trispecific Proteins And Methods Of Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.